Cargando…
Use of a Novel Clinical Decision Support Tool for Pharmacist-Led Antimicrobial Stewardship in Patients with Normal Procalcitonin
In 2018, a clinical decision support (CDS) tool was implemented as part of a “daily checklist” for frontline pharmacists to review patients on antibiotics with procalcitonin (PCT) <0.25 mcg/L. This study used a retrospective cohort design to assess change in antibiotic use from pharmacist interve...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8396243/ https://www.ncbi.nlm.nih.gov/pubmed/34449706 http://dx.doi.org/10.3390/pharmacy9030136 |
_version_ | 1783744327983300608 |
---|---|
author | Watkins, Andrew B. Van Schooneveld, Trevor C. Reha, Craig G. Anderson, Jayme McGinnis, Kelley Bergman, Scott J. |
author_facet | Watkins, Andrew B. Van Schooneveld, Trevor C. Reha, Craig G. Anderson, Jayme McGinnis, Kelley Bergman, Scott J. |
author_sort | Watkins, Andrew B. |
collection | PubMed |
description | In 2018, a clinical decision support (CDS) tool was implemented as part of a “daily checklist” for frontline pharmacists to review patients on antibiotics with procalcitonin (PCT) <0.25 mcg/L. This study used a retrospective cohort design to assess change in antibiotic use from pharmacist interventions after this PCT alert in patients on antibiotics for lower respiratory tract infections (LRTI). The secondary outcome was antibiotic days of therapy (DOT), with a subgroup analysis examining antibiotic use and the length of stay (LOS) in patients with a pharmacist intervention. From 1/2019 to 11/2019, there were 165 alerts in 116 unique patients on antibiotics for LRTI. Pharmacists attempted interventions after 34 (20.6%) of these alerts, with narrowing spectrum or converting to oral being the most common interventions. Pharmacist interventions prevented 125 DOT in the hospital. Vancomycin was the most commonly discontinued antibiotic with an 85.3% use reduction in patients with interventions compared to a 27.4% discontinuation in patients without documented intervention (p = 0.0156). The LOS was similar in both groups (median 6.4 days vs. 7 days, p = 0.81). In conclusion, interventions driven by a CDS tool for pharmacist-driven antimicrobial stewardship in patients with a normal PCT resulted in fewer DOT and significantly higher rates of vancomycin discontinuation. |
format | Online Article Text |
id | pubmed-8396243 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-83962432021-08-28 Use of a Novel Clinical Decision Support Tool for Pharmacist-Led Antimicrobial Stewardship in Patients with Normal Procalcitonin Watkins, Andrew B. Van Schooneveld, Trevor C. Reha, Craig G. Anderson, Jayme McGinnis, Kelley Bergman, Scott J. Pharmacy (Basel) Article In 2018, a clinical decision support (CDS) tool was implemented as part of a “daily checklist” for frontline pharmacists to review patients on antibiotics with procalcitonin (PCT) <0.25 mcg/L. This study used a retrospective cohort design to assess change in antibiotic use from pharmacist interventions after this PCT alert in patients on antibiotics for lower respiratory tract infections (LRTI). The secondary outcome was antibiotic days of therapy (DOT), with a subgroup analysis examining antibiotic use and the length of stay (LOS) in patients with a pharmacist intervention. From 1/2019 to 11/2019, there were 165 alerts in 116 unique patients on antibiotics for LRTI. Pharmacists attempted interventions after 34 (20.6%) of these alerts, with narrowing spectrum or converting to oral being the most common interventions. Pharmacist interventions prevented 125 DOT in the hospital. Vancomycin was the most commonly discontinued antibiotic with an 85.3% use reduction in patients with interventions compared to a 27.4% discontinuation in patients without documented intervention (p = 0.0156). The LOS was similar in both groups (median 6.4 days vs. 7 days, p = 0.81). In conclusion, interventions driven by a CDS tool for pharmacist-driven antimicrobial stewardship in patients with a normal PCT resulted in fewer DOT and significantly higher rates of vancomycin discontinuation. MDPI 2021-08-06 /pmc/articles/PMC8396243/ /pubmed/34449706 http://dx.doi.org/10.3390/pharmacy9030136 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Watkins, Andrew B. Van Schooneveld, Trevor C. Reha, Craig G. Anderson, Jayme McGinnis, Kelley Bergman, Scott J. Use of a Novel Clinical Decision Support Tool for Pharmacist-Led Antimicrobial Stewardship in Patients with Normal Procalcitonin |
title | Use of a Novel Clinical Decision Support Tool for Pharmacist-Led Antimicrobial Stewardship in Patients with Normal Procalcitonin |
title_full | Use of a Novel Clinical Decision Support Tool for Pharmacist-Led Antimicrobial Stewardship in Patients with Normal Procalcitonin |
title_fullStr | Use of a Novel Clinical Decision Support Tool for Pharmacist-Led Antimicrobial Stewardship in Patients with Normal Procalcitonin |
title_full_unstemmed | Use of a Novel Clinical Decision Support Tool for Pharmacist-Led Antimicrobial Stewardship in Patients with Normal Procalcitonin |
title_short | Use of a Novel Clinical Decision Support Tool for Pharmacist-Led Antimicrobial Stewardship in Patients with Normal Procalcitonin |
title_sort | use of a novel clinical decision support tool for pharmacist-led antimicrobial stewardship in patients with normal procalcitonin |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8396243/ https://www.ncbi.nlm.nih.gov/pubmed/34449706 http://dx.doi.org/10.3390/pharmacy9030136 |
work_keys_str_mv | AT watkinsandrewb useofanovelclinicaldecisionsupporttoolforpharmacistledantimicrobialstewardshipinpatientswithnormalprocalcitonin AT vanschooneveldtrevorc useofanovelclinicaldecisionsupporttoolforpharmacistledantimicrobialstewardshipinpatientswithnormalprocalcitonin AT rehacraigg useofanovelclinicaldecisionsupporttoolforpharmacistledantimicrobialstewardshipinpatientswithnormalprocalcitonin AT andersonjayme useofanovelclinicaldecisionsupporttoolforpharmacistledantimicrobialstewardshipinpatientswithnormalprocalcitonin AT mcginniskelley useofanovelclinicaldecisionsupporttoolforpharmacistledantimicrobialstewardshipinpatientswithnormalprocalcitonin AT bergmanscottj useofanovelclinicaldecisionsupporttoolforpharmacistledantimicrobialstewardshipinpatientswithnormalprocalcitonin |